Company Mateon Therapeutics Inc OTC Bulletin Board
Equities
Biotechnology & Medical Research
End-of-day quote
Other stock markets
|
||
- USD | - |
Business Summary
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Biopharmaceutical
100.0
%
| 0 | nan % | 0 | 100.0 % | - |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
100.0
%
| 0 | nan % | 0 | 100.0 % | - |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Vuong Trieu
CEO | Chief Executive Officer | 59 | 21/04/19 |
Director of Finance/CFO | 57 | 30/06/19 | |
Seymour H. Fein
CTO | Chief Tech/Sci/R&D Officer | 75 | 05/01/20 |
Anthony Maida
CTO | Chief Tech/Sci/R&D Officer | 59 | 10/05/20 |
Saran Saund
PRN | Corporate Officer/Principal | 66 | 31/10/19 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Steven King
BRD | Director/Board Member | 59 | 10/05/20 |
Anthony Maida
CTO | Chief Tech/Sci/R&D Officer | 59 | 10/05/20 |
Vuong Trieu
CEO | Chief Executive Officer | 59 | 21/04/19 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 398,664,555 | 179,523,741 ( 45.03 %) | 0 | 45.03 % |
Company contact information
Sector
1st Jan change | Capi. | |
---|---|---|
+3.22% | 108B | |
+11.01% | 104B | |
+1.28% | 22.33B | |
-11.94% | 22.19B | |
-7.05% | 18.69B | |
-38.36% | 17.74B | |
-10.06% | 17.64B | |
+4.79% | 14.05B | |
+35.13% | 12.51B |
- Stock Market
- Equities
- OTLC Stock
- Stock
- Company Mateon Therapeutics Inc